Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts.

Bamgbola OF, Kaskel FJ, Coco M.

Pediatr Nephrol. 2009 Mar;24(3):571-9. doi: 10.1007/s00467-008-0954-3. Epub 2008 Sep 18.

PMID:
18800231
2.

Predictors of erythropoietin responsiveness in chronic hemodialysis patients.

Tonelli M, Blake PG, Muirhead N.

ASAIO J. 2001 Jan-Feb;47(1):82-5.

PMID:
11199321
3.

Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.

Gunnell J, Yeun JY, Depner TA, Kaysen GA.

Am J Kidney Dis. 1999 Jan;33(1):63-72.

PMID:
9915269
4.

Factors related to erythropoietin hypo-responsiveness in patients on chronic peritoneal dialysis.

Wei M, Bargman JM, Oreopoulos DG.

Int Urol Nephrol. 2007;39(3):935-40. Epub 2007 May 30.

PMID:
17534732
5.

Role of folate deficiency on erythropoietin resistance in pediatric and adolescent patients on chronic dialysis.

Bamgbola OF, Kaskel F.

Pediatr Nephrol. 2005 Nov;20(11):1622-9. Epub 2005 Aug 20.

PMID:
16133045
6.

Quotidian nocturnal hemodialysis improves cytokine profile and enhances erythropoietin responsiveness.

Yuen D, Richardson RM, Fenton SS, McGrath-Chong ME, Chan CT.

ASAIO J. 2005 May-Jun;51(3):236-41.

PMID:
15968953
7.

Prevalence and correlates of anemia and uncontrolled anemia in chronic hemodialysis patients--the Campania Dialysis Registry.

Di Iorio B, Cirillo M, Bellizzi V, Stellato D, De Santo NG; Campania Dialysis Registry Research Group.

Int J Artif Organs. 2007 Apr;30(4):325-33.

PMID:
17520570
8.

Can acidosis and hyperphosphataemia result in increased erythropoietin dosing in haemodialysis patients?

Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB.

Nephrology (Carlton). 2006 Oct;11(5):394-9.

PMID:
17014551
9.
10.
11.

Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.

Pilkey RM, Morton AR, Iliescu EA.

Adv Perit Dial. 2001;17:153-7.

PMID:
11510266
12.

Challenging the validity of the EPO index.

Kaysen GA, Müller HG, Ding J, Chertow GM.

Am J Kidney Dis. 2006 Jan;47(1):166.

PMID:
16377397
13.

Association between erythropoietin responsiveness and body composition in dialysis patients.

Kotanko P, Thijssen S, Levin NW.

Blood Purif. 2008;26(1):82-9. doi: 10.1159/000110571. Epub 2008 Jan 10.

PMID:
18182803
14.

Angiotensin-converting enzyme gene polymorphism and erythropoietin requirement.

Varagunam M, McCloskey DJ, Sinnott PJ, Raftery MJ, Yaqoob MM.

Perit Dial Int. 2003 Mar-Apr;23(2):111-5.

15.

The association of race with erythropoietin dose in patients on long-term hemodialysis.

Lacson E Jr, Rogus J, Teng M, Lazarus JM, Hakim RM.

Am J Kidney Dis. 2008 Dec;52(6):1104-14. doi: 10.1053/j.ajkd.2008.07.026. Epub 2008 Sep 27.

PMID:
18824287
16.

Use of erythropoietin before the initiation of dialysis and its impact on mortality.

Fink J, Blahut S, Reddy M, Light P.

Am J Kidney Dis. 2001 Feb;37(2):348-55.

PMID:
11157377
17.

Gender modulates responsiveness to recombinant erythropoietin.

Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman EA.

Am J Kidney Dis. 2001 Sep;38(3):518-22.

PMID:
11532683
18.

Trends in anemia management among US hemodialysis patients.

Coladonato JA, Frankenfield DL, Reddan DN, Klassen PS, Szczech LA, Johnson CA, Owen WF Jr.

J Am Soc Nephrol. 2002 May;13(5):1288-95.

19.

Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.

Fujita Y, Inoue S, Horiguchi S, Kuki A.

Miner Electrolyte Metab. 1995;21(1-3):50-4.

PMID:
7565462
20.

Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy.

Sirken G, Kung SC, Raja R.

ASAIO J. 2003 Jul-Aug;49(4):422-5.

PMID:
12918584
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk